These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2689783)

  • 41. Endocrine actions of opioids.
    Pfeiffer A; Herz A
    Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endogenous opioids and the control of LH secretion during the reproductive cycle in the ram induced by treatment with melatonin.
    Lincoln GA
    Reprod Nutr Dev (1980); 1988; 28(2B):527-39. PubMed ID: 3413345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
    Van Vugt DA; Lam NY; Ferin M
    Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous opioid inhibitory tone on LH secretion in normal puberty and in several pubertal disturbances.
    Bernasconi S; Petraglia F; Iughetti L; Facchinetti F; Marcellini C; Giovannelli G; Genazzani AR
    Acta Endocrinol Suppl (Copenh); 1986; 279():196-201. PubMed ID: 3465161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in the responsiveness of luteinizing hormone secretion to infusion of the opioid antagonist naloxone throughout male sexual maturation.
    Ulloa-Aguirre A; Mendez JP; Gonzalez-Castillo A; Carranza-Lira S; Garza-Flores J; Peres-Palacios G
    Clin Endocrinol (Oxf); 1988 Jul; 29(1):17-28. PubMed ID: 3073879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
    Berga SL; Yen SS
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioid regulation of luteinizing hormone in amenorrheic patients after therapy for induction of ovulation.
    Nappi C; Petraglia F; Di Meo G; Minutolo M; Genazzani AR; Montemagno U
    Fertil Steril; 1987 Apr; 47(4):579-83. PubMed ID: 3032691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of endogenous opioid peptides in mediating progesterone-induced disruption of the activation and transmission stages of the GnRH surge induction process.
    Richter TA; Spackman DS; Robinson JE; Dye S; Harris TG; Skinner DC; Evans NP
    Endocrinology; 2001 Dec; 142(12):5212-9. PubMed ID: 11713217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Naloxone stimulation of luteinizing hormone secretion in the female monkey: influence of endocrine and experimental conditions.
    Van Vugt DA; Bakst G; Dyrenfurth I; Ferin M
    Endocrinology; 1983 Nov; 113(5):1858-64. PubMed ID: 6414806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of hypothalamic gonadotropin-releasing hormone release by endogenous opioid peptides in the female rabbit.
    Orstead KM; Spies HG
    Neuroendocrinology; 1987 Jun; 46(1):14-23. PubMed ID: 3112599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gonadectomy influences the inhibitory effect of the endogenous opiate system on pulsatile gonadotropin secretion.
    Masotto C; Negro-Vilar A
    Endocrinology; 1988 Aug; 123(2):747-52. PubMed ID: 2840268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women.
    Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P
    J Clin Endocrinol Metab; 1990 Feb; 70(2):365-70. PubMed ID: 2105330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypoglycemia-induced suppression of luteinizing hormone (LH) secretion in intact female rhesus macaques: role of vasopressin and endogenous opioids.
    Lado-Abeal J; Clapper JA; Chen Zhu B; Hough CM; Syapin PJ; Norman RL
    Stress; 2002 Jun; 5(2):113-9. PubMed ID: 12186689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids.
    Cetel NS; Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1985 Jan; 60(1):191-6. PubMed ID: 3964791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of endogenous opiates in LH secretion during the menstrual cycle.
    Quigley ME; Yen SS
    J Clin Endocrinol Metab; 1980 Jul; 51(1):179-81. PubMed ID: 7380991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroendocrinology of opioid peptides and their role in the control of gonadotropin and prolactin secretion.
    Yen SS; Quigley ME; Reid RL; Ropert JF; Cetel NS
    Am J Obstet Gynecol; 1985 Jun; 152(4):485-93. PubMed ID: 2990210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea.
    Tay CC; Glasier AF; Illingworth PJ; Baird DT
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):599-606. PubMed ID: 8252751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Function of endogenous opioid peptides and sex steroids at the level of the central nervous system].
    Bidzińska B; Jedrzejuk D
    Postepy Hig Med Dosw; 1995; 49(4):523-30. PubMed ID: 8657646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptide-steroid interactions in brain regulation of pulsatile gonadotropin secretion.
    Negro-Vilar A; Culler MD; Masotto C
    J Steroid Biochem; 1986 Nov; 25(5B):741-7. PubMed ID: 3100869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The role of the endogenous opioid system in the pathogenesis of polycystic ovary syndrome: the altered neuroendocrine regulation of GnRH-LH is corrected after clomiphene therapy].
    Barletta C; Vagiri D; Scavo D
    Minerva Endocrinol; 1992; 17(3):107-19. PubMed ID: 1298870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.